A small molecule–kinase interaction map for clinical kinase inhibitors
作者： Miles A Fabian , William H Biggs , Daniel K Treiber , Corey E Atteridge , Mihai D Azimioara
DOI: 10.1038/NBT1068
关键词:
摘要: … of these compounds target the kinase ATP … kinases in addition to their known, primary targets. For most of the compounds tested here, the tightest interaction is with the kinase or kinases …
nature.com
sci-hub.se 
researchgate.net 参考文章(48)
Christopher J. Torrance, Peta E. Jackson, Elizabeth Montgomery, Kenneth W. Kinzler, Bert Vogelstein, Allan Wissner, Maria Nunes, Philip Frost, Carolyn M. Discafani, Combinatorial chemoprevention of intestinal neoplasia. Nature Medicine. ,vol. 6, pp. 1024- 1028 ,(2000) , 10.1038/79534
Jim R Woodburn, Susan E Ashton, Simon P Guy, Keith H Gibson, Brenda J Curry, Andrew J Barker, Alan E Wakeling, ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Research. ,vol. 62, pp. 5749- 5754 ,(2002)
Flavio Meggio, Arianna Donella Deana, Maria Ruzzene, Anna M. Brunati, Luca Cesaro, Barbara Guerra, Thomas Meyer, Helmut Mett, Doriano Fabbro, Pascal Furet, Grazyna Dobrowolska, Lorenzo A. Pinna, Different susceptibility of protein kinases to staurosporine inhibition Kinetic studies and molecular bases for the resistance of protein kinase CK2 FEBS Journal. ,vol. 234, pp. 317- 322 ,(1995) , 10.1111/J.1432-1033.1995.317_C.X
Vincent A. Pollack, Catherine DiOrio, April Theleman, Elsa G. Barbacci, Leslie R. Pustilnik, Mark Neveu, Mikel P. Moyer, Kenneth K. Iwata, Lee Arnold, Michael J. Morin, James D. Moyer, Bruce Boman, Penny Miller, Ann Cunningham, Margaret M. Reynolds, Don Sloan, Jonathan Doty, Induction of Apoptosis and Cell Cycle Arrest by CP-358,774, an Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinase Cancer Research. ,vol. 57, pp. 4838- 4848 ,(1997)
Jeanette M Wood, G Bold, Elizabeth Buchdunger, R Cozens, Stefano Ferrari, Jörg Frei, F Hofmann, Jürgen Mestan, H Mett, Terence O’Reilly, Elke Persohn, Johannes Rösel, Christian Schnell, David Stover, A Theuer, Harry Towbin, Fritz Wenger, K Woods-Cook, A Menrad, Gerhard Siemeister, M Schirner, Karl-Heinz Thierauch, Martin R Schneider, J Drevs, G Martiny-Baron, F Totzke, Dieter Marmé, PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration Cancer Research. ,vol. 60, pp. 2178- 2189 ,(2000)
Nikolas von Bubnoff, Folker Schneller, Christian Peschel, Justus Duyster, BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study The Lancet. ,vol. 359, pp. 487- 491 ,(2002) , 10.1016/S0140-6736(02)07679-1
Susan Branford, Zbigniew Rudzki, Sonya Walsh, Andrew Grigg, Chris Arthur, Kerry Taylor, Richard Herrmann, Kevin P. Lynch, Timothy P. Hughes, High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood. ,vol. 99, pp. 3472- 3475 ,(2002) , 10.1182/BLOOD.V99.9.3472
Elisabeth Buchdunger, Alex Matter, Brian J. Druker, Bcr-Abl inhibition as a modality of CML therapeutics. Biochimica et Biophysica Acta. ,vol. 1551, ,(2001) , 10.1016/S0304-419X(01)00022-1
Janet Dancey, Edward A. Sausville, Issues and progress with protein kinase inhibitors for cancer treatment. Nature Reviews Drug Discovery. ,vol. 2, pp. 296- 313 ,(2003) , 10.1038/NRD1066
Michal Vieth, Richard E. Higgs, Daniel H. Robertson, Michael Shapiro, Ellen A. Gragg, Horst Hemmerle, Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. Biochimica et Biophysica Acta. ,vol. 1697, pp. 243- 257 ,(2004) , 10.1016/J.BBAPAP.2003.11.028